Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828477 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
A Phase 4 study of Intraocular Pressure, sponsored by Bp Consulting.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00828477: Completed Phase 4 study of Intraocular Pressure, sponsored by Bp Consulting.
NCT00828477 is a Phase 4 study of Intraocular Pressure that has completed, run by Bp Consulting. The registered enrollment target is 25 participants, below the 86-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00828477, a Phase 4 study of Intraocular Pressure, has completed, sponsored by Bp Consulting.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Conditions Studied
Interventions
- DRUG Xibrom
- DRUG Nevanac
Study Locations (1)
Michigan
- Coburn-Kleinfeldt Eye Clinic - 3340 6 Mile Rd Livonia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
What the finished NCT00828477 record still lists
NCT00828477 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 86-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Intraocular Pressure appearing as the primary indexed condition, and to 2 interventions - of which Xibrom is the first listed.
NCT00828477 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00828477 about?
NCT00828477 is a clinical study titled "Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)". The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
What is the current status of trial NCT00828477?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2009-06.
What conditions does trial NCT00828477 study?
This clinical trial studies the following conditions: Intraocular Pressure.
What interventions are being tested in trial NCT00828477?
The interventions under investigation include: Xibrom (DRUG), Nevanac (DRUG).
Who is sponsoring clinical trial NCT00828477?
This trial is sponsored by Bp Consulting, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00828477 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00828477's enrollment target sits among peer trials
25 9th of 9 higher than 1 of 9 other Intraocular Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intraocular Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
Loteprednol vs. Prednisolone and Fluorometholone
COMPLETED · Phase 4
-
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
COMPLETED · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
IOP Elevation Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia